PenderFund Capital Management’s NEOPHOTONICS CORP NPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-30,300
Closed -$614K 205
2022
Q2
$614K Buy
30,300
+9,900
+49% +$151K 0.17% 54
2022
Q1
$388K Buy
20,400
+12,100
+146% +$184K 0.1% 62
2021
Q4
$161K Buy
+8,300
New +$109K 0.04% 70

Other funds holding NPTN

PenderFund Capital Management's NPTN Position: Q3 2022 in Review

PenderFund Capital Management sold out of NEOPHOTONICS CORP (NPTN) in Q3 2022, closing a stake of 30,300 shares — an estimated $614K sold.

PenderFund Capital Management first reported a position in NPTN in Q4 2021 and held it in 3 quarters. The position peaked at $614K in Q2 2022. 2 funds tracked by Wall St. Rank hold NPTN as of Q3 2022.

  • PenderFund Capital Management reported no remaining NEOPHOTONICS CORP position as of Q3 2022 after selling out during the quarter.
  • PenderFund Capital Management sold 30,300 NEOPHOTONICS CORP shares in Q3 2022, an estimated $614K.
  • PenderFund Capital Management first reported a position in NEOPHOTONICS CORP in Q4 2021 and held it in 3 quarters.
  • PenderFund Capital Management's NEOPHOTONICS CORP position peaked at $614K in Q2 2022.
  • 2 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2022.

Based on PenderFund Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.